A 3‐year interval is too short for re‐screening women testing negative for human papillomavirus: a population‐based cohort study. (12th April 2017)

• Record Type: Journal Article
• Authors: Zorzi, M; Frayle, H; Rizzi, M; Fedato, C; Rugge, M; Penon, MG; Bertazzo, A; Callegaro, S; Campagnolo, M; Ortu, F; Del Mistro, A
• Other Names: Baracco Susanna investigator.; Baboci Lorena investigator.; Amadori Alberto investigator.; Montaguti Adriana investigator.; Turrin Anna investigator.; Farruggio Angelo investigator.; Cocco Patrizia investigator.; Tumaini Lucio investigator.; Gerace Pierfrancesco investigator.; Borgato Loretta investigator.; Maso Renata investigator.; Bo Patrizio investigator.; Mari Lucia investigator.; Franzoi Roberto investigator.; Ferro Antonio investigator.
• Is Part Of: BJOG. Volume 124:Number 10(2017)
• Page Start: 1585
• Page End: 1593
• Publication Date: 2017-04-12
• Subjects: Cervical cancer -- CIN2+ -- HPV DNA test -- screening interval; Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1111/1471-0528.14575
• Languages: English
• ISSNs: 1470-0328

Abstract

Abstract : Objective: To compare the results from an initial negative human papillomavirus (HPV) test with re‐screening after 3 years in women attending two HPV‐based screening programmes. Design: Population‐based cohort study. Setting: Two cervical service screening programmes in Italy. Population: Women aged 25–64 years invited to screening from April 2009 to October 2015. Methods: Eligible women were invited to undergo an HPV test. Those with a negative HPV test went on to the next screening round 3 years later. Cytology triage was performed for HPV+ (HPV by Hybrid Capture 2) samples, with immediate colposcopy (if abnormal) and HPV re‐testing 1 year later (if negative). Main outcome measures: Participation rate, positivity at HPV and at triage, referral rate to colposcopy, positive predictive value for cervical intraepithelial neoplasia grade 2+ (CIN2+) at colposcopy, and detection rate for CIN2+. Results: We present the results from 48 751 women at the first screening and 22 000 women at re‐screening 3 years later. The response rate was slightly higher at the second screening (74.5 versus 72.1% at the first screening; referral rate, RR 1.11; 95% confidence interval, 95% CI, 1.07–1.14). Compared with the first screening, we observed a significant reduction at the second screening in terms of HPV positivity (RR 0.55, 95% CI 0.51–0.60), referral rate to colposcopy (RR 0.47, 95% CI 0.41–0.53), CIN2+ detection rate (RR 0.24, 95% CI 0.13–0.39), and positive predictive value (PPV) for CIN2+ at colposcopy (RR 0.51, 95% CI 0.29–0.87). Conclusions: The very low frequency of disease and inadequate PPV at colposcopy indicate that a 3‐year interval after a negative HPV test is too short. Tweetable abstract: Three years after a negative HPV the frequency of cervical disease is so low that re‐screening is inefficient. Tweetable abstract: After a negative HPV test the frequency of cervical disease is so low at 3 years that re‐screening is inefficient.